Afasevikumab is under investigation in clinical trial NCT01480310 (Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.